Sygnature Discovery is the UK’s largest independent provider of integrated drug discovery resource and expertise. Our mission is to accelerate the discovery of new medicines from the laboratory into development to treat patients with a range of debilitating and fatal diseases.
Sygnature adds significant value to collaborations by providing advanced scientific knowledge and intellectual input to accelerate clients’ drug discovery projects from hit through to pre-clinical candidate. We have an enviable track record of success for our clients. As of November 2015, there are 5 drug candidates in the clinic and 15 compounds in pre-clinical development which were invented at Sygnature.
Sygnature Discovery operates a fully-enabled research facility in Nottingham, UK, which houses 7 modern, purpose-built laboratories and over 110 experienced scientists. From 2017, we will be located in a new, flagship facility housing over 200 employees.